Propriedade e atividade de insiders de Halozyme Therapeutics, Inc. (HALO): operações de insiders, negociações do Senado e da Câmara dos EUA e ações em circulação. Acompanhe como executivos e políticos negociam a ação.
Preço
| Preço | $108.44 |
| Capitalização | $12.9B |
| Bolsa | NASDAQ |
| País | US |
Operações Recentes de Insiders
| Data | Insider | Tipo | Ações | Valor |
|---|---|---|---|---|
| 2026-09-11 | Torley Helen | M-Exempt | 20,000 | $368K |
| 2026-09-09 | Torley Helen | S-Sale | 13,304 | $1.4M |
| 2026-09-10 | Torley Helen | S-Sale | 14,588 | $1.6M |
| 2026-09-11 | Torley Helen | S-Sale | 15,492 | $1.7M |
| 2026-09-09 | Torley Helen | S-Sale | 6,596 | $711K |
| 2026-09-10 | Torley Helen | S-Sale | 5,412 | $582K |
| 2026-09-09 | Torley Helen | S-Sale | 100 | $11K |
| 2026-09-11 | Torley Helen | S-Sale | 4,508 | $485K |
| 2026-09-09 | Torley Helen | M-Exempt | 20,000 | $368K |
| 2026-09-10 | Torley Helen | M-Exempt | 20,000 | $368K |
Balanço (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caixa e Equivalentes | $66.8M | $168.7M | $57.9M | $120.2M | $147.7M | $118.7M | $234.2M | $118.4M | $115.8M | $133.8M |
| Investimentos de Curto Prazo | $138.2M | $300.5M | $296.6M | $301.1M | $220.3M | $622.2M | $128.6M | $217.6M | $480.2M | $9.0M |
| Contas a Receber | $15.7M | $22.1M | $30.0M | $59.4M | $97.7M | $91.0M | $231.1M | $234.2M | $308.5M | $441.3M |
| Estoque | $14.6M | $5.1M | $22.6M | $29.4M | $60.7M | $53.9M | $100.1M | $127.6M | $141.9M | $176.5M |
| Ativos Circulantes | $256.5M | $510.4M | $427.8M | $543.4M | $554.8M | $926.3M | $739.0M | $746.4M | $1.09B | $825.2M |
| Imobilizado | $4.3M | $3.5M | $7.5M | $10.9M | $10.6M | $8.8M | $75.6M | $74.9M | $75.0M | $82.1M |
| Ágio | 0 | 0 | 0 | 0 | 0 | 0 | $409.0M | $416.8M | $416.8M | $580.4M |
| Ativos Intangíveis | 0 | 0 | 0 | 0 | 0 | 0 | $546.7M | $472.9M | $401.8M | $981.5M |
| Ativos Totais | $261.5M | $519.9M | $440.2M | $565.9M | $579.9M | $1.10B | $1.84B | $1.73B | $2.06B | $2.53B |
| Contas a Pagar | $3.6M | $7.9M | $4.1M | $6.4M | $1.9M | $1.5M | $17.7M | $11.8M | $10.2M | $20.9M |
| Dívida de Curto Prazo | $17.4M | $77.2M | $91.5M | $19.5M | $397.2M | $89.4M | $13.3M | 0 | 0 | 0 |
| Passivos Circulantes | $54.6M | $131.3M | $149.4M | $85.6M | $421.4M | $117.1M | $130.8M | $112.5M | $139.1M | $177.1M |
| Dívida de Longo Prazo | $199.2M | $125.1M | $34.9M | $383.0M | 0 | $787.3M | $1.49B | $1.50B | $1.51B | $2.14B |
| Passivos Totais | $294.0M | $311.6M | $191.4M | $474.1M | $428.9M | $907.5M | $1.67B | $1.65B | $1.70B | $2.48B |
| Reservas | -$585.3M | -$522.4M | -$531.4M | -$603.7M | -$474.6M | -$58.9M | $143.2M | $90.5M | $359.9M | $54.8M |
| Patrimônio Líquido | -$32.5M | $208.4M | $248.9M | $91.8M | $151.0M | $197.0M | $169.8M | $83.8M | $363.8M | $48.8M |
| Dívida Total | $216.6M | $202.4M | $126.4M | $402.6M | $397.2M | $876.7M | $1.51B | $1.50B | $1.51B | $2.14B |
| Dívida Líquida | $11.6M | -$266.9M | -$228.1M | -$18.7M | $29.2M | $135.8M | $1.14B | $1.16B | $909.7M | $2.00B |
| Capital de Giro | $201.9M | $379.0M | $278.5M | $457.8M | $133.4M | $809.1M | $608.2M | $633.9M | $946.2M | $648.1M |
Saúde financeira
| Dívida / Patrimônio | 14.95 |
| Liquidez corrente | 2.71 |
Rentabilidade
| Margem bruta | 78.18% |
| Margem operacional | 56.77% |
| Margem líquida | 24.86% |
Empresas relacionadas: ABVX · ATR · CAI · CORT · CYTK · GRFS · HSIC
Explorar setor: Healthcare · Biotechnology
Mais seções de HALO: Resumo · Financeiros · Avaliação · Estatísticas · Estimativas · Técnico · Notícias · Eventos
Descubra mais: Radar — sinais de ações subvalorizadas · Academia de Investimento — aprenda a analisar ações